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Abstract 
Adenovirus-mediated gene transfer to retinal cells was evaluated using the replication-defective r combinant adenovirus vector Ad2/CMVlacZ-1 
(coding for /I-galactosidase) both in an in vitro murine culture model and in vivo in adult mice. In vitro, no difference in infectability of neuronal 
and glial cells was observed, and 5096 of neurons expressed the exogenous gene at low viral concentration (10 pfulcell). In vivo, intraocular injection 
of 3 x IO6 pfu Ad2/CMVlacZ-1 resulted in expression of the transferred /3galactosidase gene in retinal pigment epithelium and ganglion cells. These 
results demonstrate that Ad2lCMVkzcZ-1 is an effective vector for gene transfer into retinal cells. 
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1. Introductioll 
Inherited retinal degenerations comprise a genetically 
heterogeneous group of diseases responsible for a sub- 
stantial proportion of human blindness. Numerous 
causal gene defects for some of these dystrophies have 
been described (for reviews see [ 1,2]), and in the majority 
of cases the mutations reside in genes expressed primar- 
ily in the retinal photoreceptor neurons. While investiga- 
tions to unravel the underlying pathophysiology of these 
insidious diseases continue, techniques to transfer genes 
to postmitotic cells such as neurons, with the objective 
of correcting genetic defects, are continually being devel- 
oped and refined. The most efficient of these have in- 
volved the use of recombinant viral delivery systems, 
including herpes virus vectors [3-51, and replication-de- 
fective adenoviruses (for review see [6]). Herpes simplex 
type l-derived vectors have the attraction of being natu- 
rally neurotropic, but cytotoxicity and uncertainty of 
long-term safety of these viruses remain important prob- 
lems [7-91. Replication-defective recombinant adeno- 
virus vectors have emerged as favourable vehicles for the 
transfer of exogenous genes owing to their efficient abil- 
ity to infect a variety of terminally-differentiated cells, 
including neurons. Further, the low pathogenicity and 
high efficiency of adenoviral gene delivery into the cen- 
tral nervous system suggest that these vectors may have 
a general applicability towards the therapeutic correc- 
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tion of inherited retinal diseases. We have therefore in- 
vestigated transfer of the E. coli 1acZ gene into murine 
retinal cells in vitro and in vivo, using the replication- 
deficient recombinant type 2 adenovirus vector Ad21 
CMVlacZ-1 [IO]. 
2. Experimental 
2.1. Cell culture 
Retinas from l-5 days postnatal C3H mice were dissociated by tryp- 
sinization [1 11. The dissociated cells were suspended in culture medium 
and seeded on tissue culture chamber slides at 0.5-l x 104 cells/ml and 
maintained as described [1 11. 
2.2. In vitro adenovirus gene delivery 
Adenoviral stocks were prepared, purified and titred as described 
previously [12]. AdUCMVlacZ-1 is a replication-deficient recombinant 
adenovirus deleted in the El region and retaining the E3 region [lo]. 
Mouse retinal cell cultures (l-2 x lo5 cells per well) were infected with 
virus suspension at dirferent itres and incubated at 35’C. After infec- 
tion, cultures were maintained for 24-96 hat 35”C, t?xed in 4% parafor- 
maldehyde, and assayed in situ for/Lgalactosidase (&gal) activity using 
the chromogenic /I-gal substrate, X-gal [13]. 
2.3. Immunohistochemistry 
Polyclonal anti-neurof&nnent (NF) and anti&al fibrillary acidic 
protein (GFAP) primary antibodies (Sigma) were used to discriminate, 
respectively, neurons and glial cells. Paraformaldehyde-Oxed retinal cell 
cultures, following X-gal staining, were processed using the classical 
peroxidase-anti-peroxidase. technique [141. 
2.4. In vivo a&virus gene delivery 
BAIBlc mice, 6-8 weeks old, were anaesthetixed and AdUCMVlacZ- 
1 viral suspension (3 X lo6 pfu (plaque-forming units)) or 0.9% saline 
was injected intraocularly vicinal to the retina. After 24 h the mice were 
killed, their eyes enucleated and 6xed in 4% paraformaldehyde, and 
stained with X-gal as described above. Frozen sections (10 pm) were 
then processed for immunohistochemistry. 
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Fig. 1. Effect of Ad2/CMVlacZ-1 concentration on transferred /J-galactosidase gene expression in retinal cell culture. Retinal cells were infected with 
different concentrations of Ad2/CMVZacZ-1, and /?-gal activity was assessed after 24 h by scoring the percentage of blue-stained cells. Neurons and 
glial cells are defined as those giving positive immunoreactivity with antibodies to NF and GFAP respectively. Values are the mean + S.D. from three 
independent experiments. 
3. Results and discussion 
The culture of dissociated murine retinas provides a 
model system to assess the effectiveness of adenoviral 
infection of specific cell types in the absence of in vivo 
three-dimensional structural impediments. The expres- 
sion of la& reporter gene, coding for /l-gal, permits the 
detection of successfully infected cells. No X-gal staining 
was detectable in non-infected cultures. 
3.1. Quantzjkation of reporter gene transfer in vitro 
Murine retinal cell cultures consisted of approximately 
equal populations of neuronal and glial cells as deter- 
mined by immunoreactivity with antibodies to the corre- 
sponding marker proteins. Cultures infected with Ad2/ 
CMVlacZ-1 at multiplicities from 1.25 to 50 pfu/cell 
yielded detectable xpression of the reporter gene in - 10 
to 65% of the total cells at 24 h post-infection (Fig. 1). 
Over the same range of moi (multiplicity of infection), 
the percentage of /I-gal-positive neurons increased from 
-5 to 95%. At 10 pfu/cell, 50% of neurons were B-gal 
positive, an efficiency 2.5 times greater than that re- 
ported with an adenovirus type 5 vector used to infect 
neuronal cultures from rat brain [15]. This difference 
may relate to the particular vector promoters used (CMV 
vs. RSV LTR) and most probably also to the cell culture 
origin and preparation. Infectability of retinal cells was 
tested as a function of time in culture at 1.25 pfu/cell 
Ad2/CMVZacZ-1 (Fig. 2). Expression of /?-gal reached a 
plateau at 48 h post-infection with -30% of cells positive 
in agreement with data previously reported on neuronal 
brain cell cultures [ 151. Analysis of the long-term expres- 
sion of the reporter gene in vitro is in progress. Through- 
out this experimental series, the percentage of /3-gal-pos- 
itive neurons and glial cells was similar, suggesting that 
the infectivity of Ad2JCMVlacZ-1 was independent of 
retinal cell type. This contrasts with a previous report in 
which the infectivity of an adenovirus type 5 vector was 
four times lower for glial cells than for neurons in brain 
cell cultures [15]. This divergence could similarly arise 
from differences in the culture origin and preparation or 
in the promoter driving the 1acZ gene. 
3.2. Characterization of infected cells in vitro 
Since cultures of cells dissociated from early postnatal 
mouse retinas lack the in vivo three-dimensional struc- 
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Fig. 2. Time course of transferred B-galactosidase expression in mouse retinal cell culture. Retinal cells were infected with 1.25 moi AdUCMVlocZ-1, 
and p-gal activity was evaluated at different times after infection by scoring the percentage of blue-stained cells. Neurons and glial cells are defined 
as those giving positive immunoreactivity with antibodies to NF and GFAP respectively. Values are the mean f S.D. from three independent 
experiments. 
ture, the identification of specific cell types becomes es- labelled by anti-GFAP antibody (Fig. 3A,C,E). The frl- 
sential. We characterized the infected cell types by using amentous nature of the antigen could be clearly dis- 
specific antibodies which distinguish between neurons cerned in the infected glial cells (Fig. 3C,E), but distinc- 
and glial cells (respectively anti-NF and anti-GFAP), in tion between Mi.iller cells and astrocytes, the major 
conjunction with histochemical detection ofg-gal expres- classes of retinal glial cells, remains to be established. 
sion. Light microscopic observations confirmed that the GFAP-negative flattened cells (Fig. 3C), p-gal positive, 
B-gal expression, resulting in a blue staining, was most were possibly endothelial or pigment epithelial cells or 
intensely concentrated in the retinal cell nuclei. The ex- fibroblasts, as suggested in previous characterizations of 
pression of the IucZ gene is targeted to the nucleus due retinal cultures [16,171. Anti-NF antibody labelled cells 
to the presence of the SV40 nuclear localization signal. with clearly differing morphologies. The class of cells 
Typically, expression is detectable in the perinuclear re- seen most frequently consisted of small spherical cells 
gion, presumably at the nuclear pores. While some of the associated in clusters and found aligned along the proc- 
material may actually cross the nuclear membrane, the esses of other cells (Fig. 3B,D). A proportion of these 
majority of the protein appears to remain outside. Loss cells could correspond to rod photoreceptors, lacking 
of association with the nuclear membrane during frxa- morphologically identifiable outer segments, as demon- 
tion and staining leads to the appearance of ‘leakage’ strated by Akagawa and Barnstable in rat retinal cell 
into the cytoplasm (Fig. 3C). Based on an assessment of culture [16]. A second class of NF-positive cells seen in 
total cell numbers of infected and control cultures, no these cultures had a typical neuronal morphology (Fig. 
apparent cytotoxic effects due to virus infection or to 3B,F). These generally bipolar or tripolar cells produced 
expression of the transferred B-gal gene were evident. long processes which ramified and formed a complex 
Infected retinal cells also showed no morphological meshwork. However, their morphology alone did not 
changes compared with controls. The underlying mono- allow subclassification into bipolar, amacrine and gan- 
layer of flat cells, on which the neuronal cells adhere, was glion cells and further analysis using specific antibodies 
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Fig. 3. Transferred b-galactosidase xpression in vitro and in vivo. Mouse retinal cell cultures were infected with AdUCMVZacZ-1 at 2.5 moi (C-F; 
uninfected controls: A, B). Cultures stained immunohistochemically after incubation with anti-GFAP (A,C,E) and anti-NF (B,D,F) antibodies. Glial 
cells labelled with anti-GFAP, showed the filamentous nature of the antigen (A,C,E). Immunoreactive glial cells displayed a nuclear X-gal staining 
(C: arrow; E: open arrow) and diffusion in the cytoplasm (C: asterisk). Clusters of small neuronal cells (B and D) attached occasionally (B asterisk) 
to cellular processes. Bipolar (E filled arrow) and multipolar cells (B and F: arrows) with long processes and occasionally with a pyramidal 
morphology (F: arrow) were observed. Retinal frozen sections (10 pm) from mice (n = 3; 24 h post-intraocular injection with Ad2/CMVlacZ-1 at 
3 x lo6 pfu) were stained for B-gal and then labelled with anti-NF antibody (G,H). Retinal pigment epithelium (RPE) cells, adjacent o photoreceptors 
(PR), were heavily stained for B-gal (G). Ganglion cells were double labelled with X-gal blue staining and anti+@ antibody (H: arrow). A-H: 
bar = 50 pm. 
t 
for each category [17-201 will be needed. Occasionally, 
multipolar cells with more pyramidal morphology were 
observed (Fig. 3F) and could represent axonless horizon- 
tal cells [16]. 
3.3. Adenovirus gene transfer in vivo 
Pilot experiments were carried out to evaluate the abil- 
ity of Ad2/CMVlacZ-1 vector to infect retinal cells in 
vivo in adult BALBlc mice. No B-gal activity was detect- 
able in the retinas of control-injected animals (data not 
shown). By 24 h post-intraocular injection of adenovirus, 
a patchy distribution of /&gal-expressing cells was 
detected in frozen retinal sections. Retinal pigment epithe- 
lium was densely stained (Fig. 3G). Relatively large blue- 
stained cells in the ganglion cell layer also stained posi- 
tively with anti-NF antibody, indicating that ganglion 
cells were infected with the adenovirus (Fig. 3H). In 
control sections lacking primary antibody, no non-spe- 
cific immunoreactivity was observed (data not shown). 
While the efficiency of infection of retinal cells appears 
to be lower in vivo, the conditions are not directly com- 
parable with those of the in vitro state. In particular, 
age-related changes in infectability of ocular cells must 
be considered, since the cultured cells were derived from 
early postnatal animals. Additional factors may contrib- 
ute to the difference, including reduced accessibility of 
the virus to the different retinal cell layers, possibly 
partly due to the presence of interphotoreceptor matrix 
(IPM), and clearance of the injected virus by the ocular 
blood circulation. Increasing the viral titre in the injec- 
tion may compensate at least partially for these factors; 
enzymatic perturbation of the IPM could also increase 
efficiency of in vivo adenovirus-mediated gene transfer 
[21]. Extended expression of transferred genes is likely to 
be a requirement for rescue of neuronal cells, including 
photoreceptors, affected by progressive degenerative dis- 
ease. Characterization of long-term expression of the 
reporter gene in vivo is currently in progress, and the 
introduction of endogenous cell-specific promoter and 
enhancer elements may extend transgene xpression. Re- 
peated treatment at regular intervals may also serve to 
extend expression. In this regard, Ad2 vectors have been 
shown to be safe for repetitive administration to intra- 
pulmonary airway epithelia in primates and cotton rats 
[22], and a comparable assessment in the eye will be 
warranted. 
In summary, these results demonstrate that Ad21 
CMVZacZ-1 is an effective vector to achieve in vitro 
transfer and expression of the 1acZ gene in a wide range, 
and possibly all types, of retinal neurons and glial cells. 
In vivo results suggest that denovirus type 2 vectors are 
likely to be powerful tools for transduction of gene ex- 
pression and may ultimately be suitable for correcting 
inherited or acquired retinal diseases. 
While this paper was in preparation, we became aware 
of reports from other groups indicating that adeno- 
viruses could be used for gene transfer to ocular tissues 
in vivo [21,23,24]. 
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